|
|
|
|
|
|
|
05.08.25 - 14:03
|
Former Amgen SVP of Global Research and Renowned Cell Biologist Ray Deshaies Named to Iambic′s Scientific Advisory Board (Business Wire)
|
|
SAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced that Ray Deshaies, PhD, has joined its scientific advisory board. A biochemist and cell biologist, Dr. Deshaies most recently led global research for Amgen following a distinguished academic career at the California Institute of Technology.
“I am deeply impressed with Iambic's team, its platform and application of AI and machine learning to address some of the most complex challenges in cancer and drug discovery,” said Dr. Deshaies. “Iambic has differentiated itself by using its technology to uncover truly differentiated oncology candidates and rapidly advancing them into the clinic. I look forward to supporting the team's breakthrough science as they work to bring new therapies to patients.”
Prior to Amgen, Dr. Deshaies was a professor of biology at Caltech and an investigator at the Howard Hughes...
|
|
|
|
|
|
|
|
|
|
|
14.05.25 - 08:33
|
Pershing Square Holdings, Ltd. Notes Bill Ackman′s Resignation from the Universal Music Group N.V. Board of Directors (Business Wire)
|
|
Follows May 5 Announcement that Bill Ackman was Named Executive Chairman of the Board of Directors of Howard Hughes Holdings Inc. (NYSE:HHH)
LONDON--(BUSINESS WIRE)--Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today notes that Bill Ackman, CEO of PSH's Investment Manager Pershing Square Capital Management, L.P. (“Pershing Square”), has resigned from the Board of Universal Music Group N.V. (EURONEXT: UMG) with effect from the conclusion of UMG's AGM on 14 May 2025 due to increasing demands on his time from his other Pershing Square commitments including his recent Executive Chairman appointment at Howard Hughes Holdings (NYSE: HHH).
Mr. Ackman stated:
“Over the last three years, I have greatly enjoyed being a director of UMG as it has transitioned from a private company into a flourishing public enterprise. The company is extremely well positioned for future growth and profitability under the superb leadership of Sir Lucian Grainge and the entire UMG team. I am grateful to my fellow directors...
|
|
|
|
|